Indirect MSC modification strategies |
Manipulating gene transfection |
Virus transfection |
Overexpressing miR-140–5p, and alleviating OA progress through downregulating VEGFA |
Liu et al. (2022)
|
Plasmid transfection |
Upregulating circRNA_0001236, and inhibiting cartilage degradation via miR-3677–3p/Sox9 |
Mao et al. (2021)
|
Plasmid transfection |
Overexpressing lncRNA H19, and promoting chondrogenesis through miR-29b-3p/FOXO3 |
Yan et al. (2021)
|
Co-incubating donor cells with bioactive molecules |
Co-incubation with curcumin |
Reducing the oxidative stress and protecting chondrocytes |
Xu et al. (2022)
|
Co-incubation with TGF-β1 |
Enhancing the M2 polarization via miR-135b/MAPK6 axis |
Wang and Xu, (2021)
|
Co-incubation with IL-1β |
Inhibiting inflammation of OA |
Kim et al. (2021)
|
Co-incubation with LPS |
Inhibiting cartilage matrix degradation |
Duan et al. (2021)
|
Engineering cell culture micro-environment |
3D culture |
Promoting chondrogenesis |
Yan and Wu, (2020)
|
Dynamic mechanical stimulation |
Inhibiting inflammation via NF-κB signal pathway |
Liao et al. (2021)
|
Hypoxia micro-environment culture |
Enhancing cartilage repair |
Rong et al. (2021)
|
Direct EV modification strategies |
Enriching EV cargos |
Direct mixture method |
Loading COS into EVs, and promoting anabolic related genes expression of chondrocytes |
Li et al. (2021a)
|
Electroporation |
Loading KGN into EVs, and improving cartilage repair |
Xu et al. (2021)
|
Modifying EV membrane |
E7 peptide modifying EV surface |
Targeting synovial fluid-derived MSCs |
Xu et al. (2021)
|
Fusing CAP with EV surface protein |
Improving the chondrocyte target ability |
Liang et al. (2020)
|
Modifying EVs with PPD |
Regulating EV surface charge potential, and promoting EV penetration into cartilage matrix |
Feng et al. (2021)
|